Verity & Verity’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.2M | Buy |
1,325,982
+23,766
| +2% | +$633K | 2.77% | 5 |
|
|
2025
Q4 | $32.4M | Buy |
1,302,216
+17,958
| +1% | +$453K | 2.52% | 11 |
|
|
2025
Q3 | $32.7M | Buy |
1,284,258
+907,855
| +241% | +$22.4M | 2.62% | 7 |
|
|
2025
Q2 | $9.12M | Sell |
376,403
-491,599
| -57% | -$11.5M | 0.78% | 55 |
|
|
2025
Q1 | $22M | Buy |
868,002
+254,971
| +42% | +$6.67M | 1.93% | 17 |
|
|
2024
Q4 | $16.3M | Sell |
613,031
-58,323
| -9% | -$1.58M | 1.48% | 27 |
|
|
2024
Q3 | $19.4M | Buy |
671,354
+108,863
| +19% | +$3.18M | 1.9% | 18 |
|
|
2024
Q2 | $15.7M | Buy |
562,491
+56,665
| +11% | +$1.56M | 1.72% | 23 |
|
|
2024
Q1 | $14M | Buy |
505,826
+320,419
| +173% | +$8.89M | 1.56% | 28 |
|
|
2023
Q4 | $5.34M | Sell |
185,407
-266,848
| -59% | -$8.07M | 0.61% | 59 |
|
|
2023
Q3 | $15M | Buy |
452,255
+37,635
| +9% | +$1.33M | 1.88% | 21 |
|
|
2023
Q2 | $15.2M | Buy |
414,620
+40,483
| +11% | +$1.58M | 1.87% | 21 |
|
|
2023
Q1 | $15.3M | Buy |
374,137
+23,962
| +7% | +$1.03M | 1.95% | 20 |
|
|
2022
Q4 | $17.9M | Buy |
350,175
+12,121
| +4% | +$581K | 2.34% | 11 |
|
|
2022
Q3 | $14.8M | Buy |
338,054
+8,253
| +3% | +$401K | 2.38% | 12 |
|
|
2022
Q2 | $17.3M | Buy |
329,801
+2,041
| +0.6% | +$104K | 2.65% | 7 |
|
|
2022
Q1 | $17M | Buy |
327,760
+2,937
| +0.9% | +$152K | 2.35% | 11 |
|
|
2021
Q4 | $19.2M | Sell |
324,823
-794
| -0.2% | -$39.3K | 2.74% | 6 |
|
|
2021
Q3 | $14.6M | Buy |
325,617
+6,161
| +2% | +$273K | 2.18% | 10 |
|
|
2021
Q2 | $12.5M | Sell |
319,456
-160
| -0.1% | -$6.22K | 1.98% | 15 |
|
|
2021
Q1 | $12.4M | Buy |
319,616
+35,491
| +12% | +$1.26M | 2.01% | 15 |
|
|
2020
Q4 | $10.7M | Buy |
284,125
+1,438
| +0.5% | +$52.7K | 2.03% | 14 |
|
|
2020
Q3 | $9.86M | Buy |
282,687
+168,888
| +148% | +$5.92M | 2.17% | 13 |
|
|
2020
Q2 | $3.8M | Buy |
113,799
+9,275
| +9% | +$315K | 0.91% | 47 |
|
|
2020
Q1 | $3.24M | Sell |
104,524
-22,703
| -18% | -$774K | 0.91% | 47 |
|
|
2019
Q4 | $4.73M | Buy |
127,227
+427
| +0.3% | +$15.2K | 0.92% | 45 |
|
|
2019
Q3 | $4.29M | Sell |
126,800
-19,679
| -13% | -$716K | 0.91% | 44 |
|
|
2019
Q2 | $6.02M | Buy |
146,479
+7,602
| +5% | +$302K | 1.31% | 35 |
|
|
2019
Q1 | $5.6M | Sell |
138,877
-130,062
| -48% | -$5.21M | 1.28% | 29 |
|
|
2018
Q4 | $11.1M | Buy |
268,939
+3,948
| +1% | +$164K | 2.98% | 1 |
|
|
2018
Q3 | $11.1M | Buy |
264,991
+718
| +0.3% | +$27.6K | 2.67% | 5 |
|
|
2018
Q2 | $9.1M | Buy |
264,273
+26,331
| +11% | +$900K | 2.36% | 12 |
|
|
2018
Q1 | $8.01M | Buy |
237,942
+6,672
| +3% | +$229K | 2.16% | 15 |
|
|
2017
Q4 | $7.95M | Buy |
231,270
+8,919
| +4% | +$304K | 2.14% | 15 |
|
|
2017
Q3 | $7.53M | Buy |
222,351
+2,145
| +1% | +$68.9K | 2.2% | 13 |
|
|
2017
Q2 | $7.02M | Buy |
220,206
+15,259
| +7% | +$481K | 2.15% | 13 |
|
|
2017
Q1 | $6.65M | Buy |
204,947
+24,189
| +13% | +$763K | 2.07% | 16 |
|
|
2016
Q4 | $5.57M | Buy |
180,758
+6,310
| +4% | +$193K | 1.94% | 21 |
|
|
2016
Q3 | $5.61M | Buy |
174,448
+15,477
| +10% | +$518K | 2.06% | 16 |
|
|
2016
Q2 | $5.31M | Buy |
158,971
+12,926
| +9% | +$413K | 2.04% | 15 |
|
|
2016
Q1 | $4.11M | Sell |
146,045
-7,174
| -5% | -$205K | 1.74% | 31 |
|
|
2015
Q4 | $4.69M | Sell |
153,219
-3,283
| -2% | -$103K | 2.13% | 10 |
|
|
2015
Q3 | $4.66M | Sell |
156,502
-1,504
| -1% | -$48.2K | 2.28% | 6 |
|
|
2015
Q2 | $5.03M | Sell |
158,006
-1,687
| -1% | -$55K | 2.43% | 4 |
|
|
2015
Q1 | $5.27M | Buy |
159,693
+6,901
| +5% | +$219K | 2.42% | 2 |
|
|
2014
Q4 | $4.51M | Buy |
152,792
+1,509
| +1% | +$43.3K | 2.14% | 12 |
|
|
2014
Q3 | $4.24M | Buy |
151,283
+3,389
| +2% | +$95.1K | 2.13% | 7 |
|
|
2014
Q2 | $4.17M | Buy |
147,894
+15,721
| +12% | +$448K | 2.14% | 13 |
|
|
2014
Q1 | $4.03M | Buy |
132,173
+10,404
| +9% | +$310K | 2.19% | 7 |
|
|
2013
Q4 | $3.54M | Buy |
121,769
+1,316
| +1% | +$38.3K | 1.95% | 16 |
|
|
2013
Q3 | $3.28M | Buy |
120,453
+6,527
| +6% | +$178K | 1.89% | 18 |
|
|
2013
Q2 | $3.03M | Buy |
+113,926
| New | +$3.15M | 1.85% | 17 |
|
Other funds holding PFE
VCM
VPM
Verity & Verity's PFE Position: Q1 2026 in Review
Verity & Verity increased its Pfizer (PFE) stake by 1.8% in Q1 2026, buying an estimated $633K and bringing the position to 1,325,982 shares worth $37.2M. The position accounts for 2.77% of the portfolio, ranked #5.
Verity & Verity first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Verity & Verity held 1,325,982 shares of Pfizer worth $37.2M as of Q1 2026.
- Verity & Verity bought 23,766 Pfizer shares in Q1 2026, an estimated $633K.
- Pfizer made up 2.77% of Verity & Verity's portfolio in Q1 2026, its #5 holding.
- Verity & Verity first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.